International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 41 full-time employees. The firm's segments include Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Device Products and Fluorine Products. Theranostics Products segment includes production and distribution of its generic sodium iodide I-131 drug product for the treatment of hyperthyroidism and carcinoma of the thyroid. Cobalt Products segment includes the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy and various industrial applications. Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging. Fluorine Products segment is involved in the production of small-scale qualification samples of high-purity fluoride gas for various industrial applications. The company is working to launch the RadVent brand of medical devices.
Follow-Up Questions
¿Cuál es el ratio P/E de International Isotopes Inc (INIS)?
El ratio P/E de International Isotopes Inc es 3691.183
¿Quién es el CEO de International Isotopes Inc?
Mr. Shahe Bagerdjian es el President de International Isotopes Inc, se unió a la empresa desde 2023.
¿Qué tal es el rendimiento del precio de la acción INIS?
El precio actual de INIS es de 0.0566, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de International Isotopes Inc?
International Isotopes Inc pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de International Isotopes Inc?
La capitalización bursátil actual de International Isotopes Inc es $29.8
¿Es International Isotopes Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 0 analistas han realizado calificaciones de análisis para International Isotopes Inc, incluyendo 0 fuerte compra, 0 compra, 0 mantener, 0 venta, y 0 fuerte venta